A series of 6-and 7-piperazinyl- and -piperidinylmethylbenzoxazinones with dopamine D4 antagonist activity: Discovery of a potential atypical antipsychotic agent

被引：26

作者：

Belliotti, TR ^{[1
]}

Wustrow, DJ ^{[1
]}

Brink, WA ^{[1
]}

Zoski, KT ^{[1
]}

Shih, YH ^{[1
]}

Whetzel, SZ ^{[1
]}

Georgic, LM ^{[1
]}

Corbin, AE ^{[1
]}

Akunne, HC ^{[1
]}

Heffner, TG ^{[1
]}

Pugsley, TA ^{[1
]}

Wise, LD ^{[1
]}

机构：

[1] Warner Lambert Co, Parke Davis Pharmaceut Res Div, Ann Arbor, MI 48105 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1999年 / 42卷 / 25期

关键词：

D O I：

10.1021/jm990277d

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

As part of a program to develop dopamine D4 antagonists for the treatment of schizophrenia, we discovered a series of 6- and 7-(phenylpiperazinyl)- and -(phenylpiperidinyl)methylbenzoxazinones through mass screening of our compound library. A structure-activity relationship SAR study was carried out involving substituents on the phenyl ring, and several selective D4 antagonists were identified. The 7-substituted benzoxazinones showed more activity in neurochemical and behavioral tests than the 6-substituted series. One of the most potent and selective compounds (26) was found to have potent activity in animal tests predictive of antipsychotic activity in humans after oral administration. This paper describes the SAR of the benzoxazinone series and the preclinical characterization of 26.

引用

页码：5181 / 5187

页数：7

共 36 条

[11] The agonist activities of the putative antipsychotic agents, L-745,870 and U-101958 in HEK293 cells expressing the human dopamine D4.4 receptor
Gazi, L
Bobirnac, I
Danzeisen, M
Schüpbach, E
Bruinvels, AT
Geisse, S
Sommer, B
Hoyer, D
Tricklebank, M
Schoeffter, P
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (05) : 889 - 896
[12] GIROS B, 1990, CR ACAD SCI III-VIE, V311, P501
[13] VILSMEIER-HAACK REACTION WITH GLUTARIMIDES - SYNTHESIS OF 2,6-DICHLORO-1,4-DIHYDROPYRIDINE-3,5-DICARBOXALDEHYDES
GUZMAN, A
ROMERO, M
MADDOX, ML
MUCHOWSKI, JM
[J]. JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (22) : 5793 - 5797
[14] Dopamine, the prefrontal cortex and schizophrenia
Knable, MB
Weinberger, DR
[J]. JOURNAL OF PSYCHOPHARMACOLOGY, 1997, 11 (02) : 123 - 131
[15] Kramer MS, 1997, ARCH GEN PSYCHIAT, V54, P567
[16] KRITTON A, 1990, DRUGS, V40, P722
[17] CLOZAPINE-ASSOCIATED AGRANULOCYTOSIS - RISK AND ETIOLOGY
KRUPP, P
BARNES, P
[J]. BRITISH JOURNAL OF PSYCHIATRY, 1992, 160 : 38 - 40
[18] 3-[[4-(4-chlorophenyl)piperazin-1-yl]methyl]-1H-pyrrolo[2,3-b]pyridine: An antagonist with high affinity and selectivity for the human dopamine D-4 receptor
Kulagowski, JJ
Broughton, HB
Curtis, NR
Mawer, IM
Ridgill, MP
Baker, R
Emms, F
Freedman, SB
Marwood, R
Patel, S
Patel, S
Ragan, CI
Leeson, PD
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (10) : 1941 - 1942
[19] MANSBACH RS, 1988, PSYCHOPHARMACOLOGY, P229
[20] Matsumoto M, 1996, J NEUROCHEM, V66, P915

← 1 2 3 4 →